Literature DB >> 7589062

Secondary prevention of myocardial infarction: impact of clinical trials on clinical practice.

Z Rumboldt, I Bozić, S Sardelić.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7589062     DOI: 10.1007/BF00198319

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  2 in total

1.  Drug utilization data in risk/benefit analyses of drugs--benefit analysis.

Authors:  F H Gross
Journal:  Acta Med Scand Suppl       Date:  1984

2.  Clinical trials versus clinical practice in the secondary prevention of myocardial infarction.

Authors:  A Agustí; J M Arnau; J R Laporte
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

  2 in total
  1 in total

Review 1.  Is aspirin underused in myocardial infarction?

Authors:  J M Arnau; A Agustí
Journal:  Pharmacoeconomics       Date:  1997-11       Impact factor: 4.981

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.